RxDoctor Payments Data

William Mehan, MD

Diagnostic Radiology · Boston, MANPI 1942421276

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $5,315 of the $5,315 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Biomarin Pharmaceutical Inc.. Among diagnostic radiology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,315in general payments, 2019–2025

Across 7 payments — averaging $759.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biomarin Pharmaceutical Inc.$5K
$314,926in research payments, 2019–2025

Across 40 payments — averaging $7873.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • F. Hoffmann-la Roche AG$145K
  • Astrazeneca UK Limited$98K
  • Annalise-ai Pty Ltd$59K
  • Biomarin Pharmaceutical Inc.$13K

What the payments were for

  • Consulting fees$5,315100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biomarin Pharmaceutical Inc.7$5,315

How this compares

$5,315 in reported general payments places this provider in the 90th percentile of 1,206 diagnostic radiology providers in Massachusetts.

See all diagnostic radiology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$146,666
Medicare patients
1,321
Services billed
7,179

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other diagnostic radiology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →